ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 51

Cigarette Smoking Has Different Impacts on ACPA and RF Production Depending on Shared Epitope Allele Status in Japanese RA Patients; A Study with the Two Independent Japanese Cohorts (IORRA and KURAMA)

Yuki Ishikawa1, Motomu Hashimoto 2, Katsunori Ikari 3, Koichiro Ohmura 4, Masao Tanaka 4, Hiromu Ito 4, Atsuo Taniguchi 3, Hisashi Yamanaka 3, Tsuneyo Mimori 4 and Chikashi Terao 5, 1Joslin Diabes Center, Boston, MA, 2Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan, 3Tokyo Women’s Medical University, Tokyo, Japan, 4Graduate School of Medicine, Kyoto University, Kyoto, Japan, 5RIKEN, Tokyo, Japan

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: ACPA, environmental factors and genetics, Rheumatoid arthritis (RA), Rheumatoid Factor

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: RA – Etiology & Pathogenesis Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: In rheumatoid arthritis (RA), cigarette smoking affects both rheumatoid factor (RF) and anti-citrullinated cyclic peptide/protein antibody (ACPA) production, but its association in relation to HLA-DRB1 alleles, especially shared epitope (SE) alleles, have been different among different races1-5. Furthermore, the impact of cigarette smoking and its cessation on levels of RF and ACPA have not been well documented. We conducted the present study to investigate the impact of cigarette smoking and cessation on RF and ACPA levels in relation to HLA-DRB1 alleles in the largest RA cohorts in Asians.

Methods: A total of 6,239 subjects from two independent Japanese cohorts were enrolled. Their precise smoking histories both before and after the onset of RA were collected in questionnaires. The latest RF and ACPA levels were used (mean disease duration 15.6 years). We defined top quadrant of levels of RF or ACPA as high levels. Associations between smoking status and positivities or high levels of ACPA or RF as well as effects of HLA-DRB1 alleles on the associations were investigated by multiple logistic regression models.

Results: Smoking at onset (SaO) was an independent risk of not only RF and ACPA positivities  (RF, odds ratio (OR) 1.52, 95% confidence interval (CI) 1.26-1.85, p=1.8×10-5; ACPA, OR 1.39, 95%CI 1.09-1.76, p=6.8×10-3), but also high levels of these autoantibodies, especially RF (Figure1; OR 2.06, 95% CI 1.70-2.48, p=7.4×10-14; ACPA OR 1.29, 95%CI 1.06-1.57, p=1.2×10-2). The larger ORs of RF than ACPA suggests that RF is more sensitive to cigarette smoking than ACPA. The effects of cigarette smoking were significantly larger in males than in females. The patients who quited smoking before onset had no longer significant risks of high autoantibody levels compared to subjects who had never smoked (RF, OR 1.33, p=0.099; ACPA, OR 1.19, p=0.093), and the risk was gradually attenuated depending on cessation years (RF, 0-10 years OR 1.34, 10-20 years OR 1.31, > 20 years OR 0.97; ACPA, 0-10 years OR 1.38, 10-20 years OR 1.01, > 20 years OR 1.12). The effect of smoking on ACPA positivity and its high level was apparent only in the presence of SE alleles, while the effect on RF positivity and its high level was apparent despite the presence of SE alleles (Figure 2 and 3) .

Conclusion: Cigarette smoking especially at RA onset is a significant risk of future high levels of ACPA and RF preferentially in males, and RF is more sensitive to smoking status than ACPA. The effect on ACPA is apparent only in the presence of SE alleles, indicating that an interaction between cigarette smoking and SE alleles affects ACPA production. On the other hand, the effect of cigarette smoking on RF production may be independent of SE alleles. Our study imply a novel potential mechanism of RA pathogenesis.

References:
1. Klareskog L, Stolt P, Lundberg K, et al. Arthritis Rheum. 2006.
2. Too CL, Yahya A, Murad S, et al. Arthritis Res Ther. 2012.
3. Lee HS, Irigoyen P, Kern M, et al. Arthritis Rheum. 2007.
4. Bang SY, Lee KH, Cho SK, Lee HS, Lee KW, Bae SC. Arthritis Rheum. 2010.
5. Murphy D, Mattey D, Hutchinson D. PLoS One. 2017.


Disclosure: Y. Ishikawa, None; M. Hashimoto, Astellas, 8, Ayum, 9, Brystol-Meyers, 8, Chugai, 9, Tanabe-Mitsubishi, 8, 9, UCB Japan, 9; K. Ikari, None; K. Ohmura, None; M. Tanaka, None; H. Ito, None; A. Taniguchi, None; H. Yamanaka, None; T. Mimori, None; C. Terao, None.

To cite this abstract in AMA style:

Ishikawa Y, Hashimoto M, Ikari K, Ohmura K, Tanaka M, Ito H, Taniguchi A, Yamanaka H, Mimori T, Terao C. Cigarette Smoking Has Different Impacts on ACPA and RF Production Depending on Shared Epitope Allele Status in Japanese RA Patients; A Study with the Two Independent Japanese Cohorts (IORRA and KURAMA) [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/cigarette-smoking-has-different-impacts-on-acpa-and-rf-production-depending-on-shared-epitope-allele-status-in-japanese-ra-patients-a-study-with-the-two-independent-japanese-cohorts-iorra-and-kurama/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cigarette-smoking-has-different-impacts-on-acpa-and-rf-production-depending-on-shared-epitope-allele-status-in-japanese-ra-patients-a-study-with-the-two-independent-japanese-cohorts-iorra-and-kurama/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology